Related Experiment Videos
SYK expression in human breast cancer
Ae Elkak1, W Al Sarakbi, K Mokbel
1The Breast Unit, St George's Hospital and Medical School, Blackshaw Road London, SW17 0QT, UK. kefahmokbel@hotmail.com.
Journal of Carcinogenesis
|April 22, 2005
Summary
Splenic tyrosine kinase (Syk) mRNA expression did not differ between breast tumors and adjacent normal tissue. Syk levels showed no significant association with breast cancer clinicopathological parameters or patient prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Splenic tyrosine kinase (Syk) is a key intracellular signaling protein.
- Syk plays roles in cell proliferation, differentiation, and phagocytosis, with notable expression in the mammary gland.
- Its specific role in breast cancer remains unclear, with limited and conflicting research.
Purpose of the Study:
- To investigate the hypothesis that Syk expression is downregulated in breast cancer compared to adjacent normal tissue (ANCT).
- To examine the association between Syk expression and various clinicopathological parameters in breast cancer patients.
Main Methods:
- Quantitative real-time PCR (RT-PCR) and Taqman methodology were used to measure Syk mRNA expression relative to ribosomal RNA.
- mRNA was extracted from 48 breast cancer specimens and matched ANCT.
- Statistical analyses included Mann-Whitney U test and Spearman's rank correlation test.
Main Results:
- Median relative Syk expression was comparable between breast tumors (0.17) and ANCT (0.18).
- No statistically significant differences in Syk expression were found between cancer and ANCT (p=0.598).
- Syk expression showed no significant correlation with patient age, tumor size, grade, receptor status, lymph node metastasis, vascular invasion, or clinical outcome.
Conclusions:
- Syk mRNA expression levels are similar in breast tumors and adjacent normal tissue.
- Breast tumor Syk expression is not significantly associated with key clinicopathological features or prognosis.